Technical
Channels

Drug Discovery

Drug Development

Drug Manufacturing

Drug Delivery

Clinical Trials

Regulatory and Legal

Alliances and Mergers

QA/QC and Compliance

Pharmaceutical Processing and Packaging

Change text size [+] [-]

PPD Earns CAP Accreditation in Singapore

Wednesday, February 10, 2010
 Email This |  Printer Friendly

PPD has announced that its global central lab operations in Singapore has earned accreditation by the College of American Pathologists (CAP).

This validates its ability to deliver high-quality, reliable data that meet standards of excellence in enhancing patient safety and speeding drug development.

The Singapore facility is the company's fourth central lab to achieve accreditation by the CAP Laboratory Accreditation Program. This internationally recognized program uses rigorous accreditation standards to help laboratories improve patient care by providing quality laboratory services.

A multidisciplinary team of practicing lab professionals inspected the facility, examining staff qualifications, laboratory equipment and facilities, safety programs and records, and overall management of laboratory operations.


Share this:   Del.icio.us | 
Digital Edition



Singapore's Preclinical R&D industry should differentiate itself in Asia by competing on quality rather than on price.
Yes
No
View results


ABOUT PHARMA ASIA | FREE SUBSCRIPTION | CONTACT US

© 2010 Ten Alps Communications Asia. All rights reserved.
Use of this Web site is subjected to its Terms and Conditions of Use. View our Privacy Policy